Save
Email
Print
Share
RSSBrowse News Stories
61 to 70 of 980 stories
view headlines only
-
Leukemia Patients Remain in Remission More Than Two Years After Engineered T Cell Therapy
December 10, 2012 — Nine of 12 leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the ... > full storyMore: -
Leukemia
Osteoporosis
Today's Healthcare
Diseases and Conditions
Wounds and Healing
Multiple Sclerosis Research
Reduced Intensity Regimen Prior to Marrow Transplant Better for Older Leukemia Patients, Study Suggests
December 9, 2012 — A new study shows that preparing older acute myeloid leukemia patients for bone marrow transplants with a reduced intensity conditioning regimen appears to be associated with higher rates of ... > full story -
Scientists Target DNA Repair to Eradicate Leukemia Stem Cells
December 9, 2012 — Despite treatment with imatinib, which targets chronic myeloid leukemia, some patients may be at risk for relapse because of leukemia stem cells that are resistant to treatment, accumulating ... > full story -
Novel Therapeutic Agents Provide Hope for Patients With Hard-to-Treat Blood Disorders
December 9, 2012 — Encouraging safety and efficacy data on novel and emerging therapies signal an important step forward in the development of treatment strategies for patients with hard-to-treat leukemia, myeloma, and ... > full story -
Pre-Clinical Data Suggests Angiocidin Effective Against Leukemia
December 9, 2012 — Angiocidin, a novel tumor-inhibiting protein, has shown in vitro and in vivo effectiveness against acute myeloid leukemia cells in pre-clinical ... > full story -
More Than a Third of High-Risk Leukemia Patients Respond to Experimental New Drug
December 9, 2012 — A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial. In more than a third of ... > full story -
New Drug Cuts Risk of Deadly Transplant Side Effect in Half
December 9, 2012 — A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a new ... > full story -
Blood Cancers: Studies Assess Genetics, Modified Treatment to Improve Outcomes, Reduce Toxicity
December 8, 2012 — Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity ... > full story -
Winning the Battle Against Leukemia: Positive Early Results in Clinical Trial for DNA Vaccine
December 7, 2012 — Early results of a trial to treat leukemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date. Furthermore, T cell immune ... > full story -
Studying Marrow, Researchers Accelerate Blood Stem Cells
December 5, 2012 — Scientists are testing a new approach to speed a patient's recovery of blood counts during a vulnerable period after a stem-cell transplant, according to a new ... > full story
Search ScienceDaily
Number of stories in archives: 137,427
more 
